Best-practice indicators in Psoriatic disease care

<br><strong>Objective: </strong>In 2016, members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), in collaboration with KPMG LLP (UK), conducted a study to measure care in psoriatic arthritis (PsA). A key finding was that centers do not usuall...

Full description

Bibliographic Details
Main Authors: Helliwell, P, Favier, G, Gladman, D, Soriano, E, Kirkham, B, Coates, L, Puig, L, Boehncke, W, Thaçi, D
Format: Journal article
Language:English
Published: Journal of Rheumatology 2019
_version_ 1797069597477699584
author Helliwell, P
Favier, G
Gladman, D
Soriano, E
Kirkham, B
Coates, L
Puig, L
Boehncke, W
Thaçi, D
author_facet Helliwell, P
Favier, G
Gladman, D
Soriano, E
Kirkham, B
Coates, L
Puig, L
Boehncke, W
Thaçi, D
author_sort Helliwell, P
collection OXFORD
description <br><strong>Objective: </strong>In 2016, members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), in collaboration with KPMG LLP (UK), conducted a study to measure care in psoriatic arthritis (PsA). A key finding was that centers do not usually have processes in place to measure the effect of improved quality of care. Our objectives were to identify and select best-practice indicators to enable PsA caregivers to assess and monitor the outcomes of specific initiatives aimed at improving care in 4 focus areas: (1) shortening time to diagnosis; (2) improving multidisciplinary collaboration; (3) optimizing disease management; and (4) improving disease monitoring.</br> <br><strong>Methods: </strong>(1) Structured review of scientific and grey literature to obtain evidence for a long list of 100 potential indicators across the 4 focus areas; (2) survey expert rheumatologists and dermatologists to review the long list and identify the most meaningful and feasible indicators for use in day-to-day practice; (3) consensus discussion to identify a shortlist of indicators based on predefined selection criteria; (4) electronic group discussion to refine definitions of shortlisted indicators and targets; and (5) review of the shortlisted indicators at the annual GRAPPA meeting in July 2018 to ensure the indicators meet the preliminary criteria.</br> <br><strong>Results: </strong>The expert group arrived at a consensus with a shortlist of 8 best-practice indicators across 4 key focus areas aligned with the patient pathway.</br> <br><strong>Conclusion: </strong>There were 8 evidence-based best-practice indicators and respective targets that were identified to enable the monitoring of quality of care and target improvements.</br>
first_indexed 2024-03-06T22:26:49Z
format Journal article
id oxford-uuid:56f0988b-0d36-42dc-9080-81c6eac867b6
institution University of Oxford
language English
last_indexed 2024-03-06T22:26:49Z
publishDate 2019
publisher Journal of Rheumatology
record_format dspace
spelling oxford-uuid:56f0988b-0d36-42dc-9080-81c6eac867b62022-03-26T16:53:33ZBest-practice indicators in Psoriatic disease careJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:56f0988b-0d36-42dc-9080-81c6eac867b6EnglishSymplectic Elements at OxfordJournal of Rheumatology2019Helliwell, PFavier, GGladman, DSoriano, EKirkham, BCoates, LPuig, LBoehncke, WThaçi, D<br><strong>Objective: </strong>In 2016, members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), in collaboration with KPMG LLP (UK), conducted a study to measure care in psoriatic arthritis (PsA). A key finding was that centers do not usually have processes in place to measure the effect of improved quality of care. Our objectives were to identify and select best-practice indicators to enable PsA caregivers to assess and monitor the outcomes of specific initiatives aimed at improving care in 4 focus areas: (1) shortening time to diagnosis; (2) improving multidisciplinary collaboration; (3) optimizing disease management; and (4) improving disease monitoring.</br> <br><strong>Methods: </strong>(1) Structured review of scientific and grey literature to obtain evidence for a long list of 100 potential indicators across the 4 focus areas; (2) survey expert rheumatologists and dermatologists to review the long list and identify the most meaningful and feasible indicators for use in day-to-day practice; (3) consensus discussion to identify a shortlist of indicators based on predefined selection criteria; (4) electronic group discussion to refine definitions of shortlisted indicators and targets; and (5) review of the shortlisted indicators at the annual GRAPPA meeting in July 2018 to ensure the indicators meet the preliminary criteria.</br> <br><strong>Results: </strong>The expert group arrived at a consensus with a shortlist of 8 best-practice indicators across 4 key focus areas aligned with the patient pathway.</br> <br><strong>Conclusion: </strong>There were 8 evidence-based best-practice indicators and respective targets that were identified to enable the monitoring of quality of care and target improvements.</br>
spellingShingle Helliwell, P
Favier, G
Gladman, D
Soriano, E
Kirkham, B
Coates, L
Puig, L
Boehncke, W
Thaçi, D
Best-practice indicators in Psoriatic disease care
title Best-practice indicators in Psoriatic disease care
title_full Best-practice indicators in Psoriatic disease care
title_fullStr Best-practice indicators in Psoriatic disease care
title_full_unstemmed Best-practice indicators in Psoriatic disease care
title_short Best-practice indicators in Psoriatic disease care
title_sort best practice indicators in psoriatic disease care
work_keys_str_mv AT helliwellp bestpracticeindicatorsinpsoriaticdiseasecare
AT favierg bestpracticeindicatorsinpsoriaticdiseasecare
AT gladmand bestpracticeindicatorsinpsoriaticdiseasecare
AT sorianoe bestpracticeindicatorsinpsoriaticdiseasecare
AT kirkhamb bestpracticeindicatorsinpsoriaticdiseasecare
AT coatesl bestpracticeindicatorsinpsoriaticdiseasecare
AT puigl bestpracticeindicatorsinpsoriaticdiseasecare
AT boehnckew bestpracticeindicatorsinpsoriaticdiseasecare
AT thacid bestpracticeindicatorsinpsoriaticdiseasecare